DIANA WADLUND: Open Payments
NPI 1407817133 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,154 in 62 payments from 21 companies in 2025. Trend: 2023 $430 · 2024 $1,624 · 2025 $1,154
Food & beverage: $1,154
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $185 |
| AstraZeneca Pharmaceuticals LP | 9 | $163 |
| Novo Nordisk Inc | 9 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $83 |
| PFIZER INC. | 4 | $72 |
| Astellas Pharma US Inc | 3 | $69 |
| Exact Sciences Corporation | 3 | $65 |
| Bausch Health US, LLC | 2 | $39 |
| Abbott Laboratories | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $35 |
Products named: VRAYLAR, CAPLYTA, Wegovy, Veozah, AIRSUPRA, The Cologuard Plus Collection Kit, FARXIGA, QULIPTA.
Industry payments across PA — which companies pay providers there.
